|
Common symptoms
|
How bad it is |
What people are taking for it |
- Severity
- Severe
- Moderate
- Mild
- None
|
|
Anxious mood
|
-
0 (0%) patients experienced severe severity
-
1 (20%) patients experienced moderate severity
-
2 (40%) patients experienced mild severity
-
2 (40%) patients experienced no severity
|
|
|
Pain
|
-
1 (20%) patients experienced severe severity
-
1 (20%) patients experienced moderate severity
-
1 (20%) patients experienced mild severity
-
2 (40%) patients experienced no severity
|
|
|
Insomnia
|
-
0 (0%) patients experienced severe severity
-
1 (20%) patients experienced moderate severity
-
1 (20%) patients experienced mild severity
-
3 (60%) patients experienced no severity
|
|
|
Fatigue
|
-
1 (20%) patients experienced severe severity
-
1 (20%) patients experienced moderate severity
-
2 (40%) patients experienced mild severity
-
1 (20%) patients experienced no severity
|
|
|
Depressed mood
|
-
0 (0%) patients experienced severe severity
-
1 (20%) patients experienced moderate severity
-
3 (60%) patients experienced mild severity
-
1 (20%) patients experienced no severity
|
|
| Treatments reported by members |
Perceived effectiveness |
Overall rating of side effects |
# of Evaluations |
|
|
-
1 (100%) experienced major perceived effectiveness
-
0 (0%) experienced moderate perceived effectiveness
-
0 (0%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
0 (0%) experienced severe side effects
-
1 (100%) experienced moderate side effects
-
0 (0%) experienced mild side effects
-
0 (0%) experienced no side effects
|
1 |
|
|
-
1 (100%) experienced major perceived effectiveness
-
0 (0%) experienced moderate perceived effectiveness
-
0 (0%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
0 (0%) experienced severe side effects
-
1 (100%) experienced moderate side effects
-
0 (0%) experienced mild side effects
-
0 (0%) experienced no side effects
|
1 |
|
|
-
0 (NaN%) experienced major perceived effectiveness
-
0 (NaN%) experienced moderate perceived effectiveness
-
0 (NaN%) experienced slight perceived effectiveness
-
0 (NaN%) experienced no perceived effectiveness
-
|
-
0 (NaN%) experienced severe side effects
-
0 (NaN%) experienced moderate side effects
-
0 (NaN%) experienced mild side effects
-
0 (NaN%) experienced no side effects
|
0 |
|
|
-
0 (NaN%) experienced major perceived effectiveness
-
0 (NaN%) experienced moderate perceived effectiveness
-
0 (NaN%) experienced slight perceived effectiveness
-
0 (NaN%) experienced no perceived effectiveness
-
|
-
0 (NaN%) experienced severe side effects
-
0 (NaN%) experienced moderate side effects
-
0 (NaN%) experienced mild side effects
-
0 (NaN%) experienced no side effects
|
0 |
|
|
-
0 (NaN%) experienced major perceived effectiveness
-
0 (NaN%) experienced moderate perceived effectiveness
-
0 (NaN%) experienced slight perceived effectiveness
-
0 (NaN%) experienced no perceived effectiveness
-
|
-
0 (NaN%) experienced severe side effects
-
0 (NaN%) experienced moderate side effects
-
0 (NaN%) experienced mild side effects
-
0 (NaN%) experienced no side effects
|
0 |
|
|
-
0 (NaN%) experienced major perceived effectiveness
-
0 (NaN%) experienced moderate perceived effectiveness
-
0 (NaN%) experienced slight perceived effectiveness
-
0 (NaN%) experienced no perceived effectiveness
-
|
-
0 (NaN%) experienced severe side effects
-
0 (NaN%) experienced moderate side effects
-
0 (NaN%) experienced mild side effects
-
0 (NaN%) experienced no side effects
|
0 |
Radiation Therapy
(Intensity-modulated radiation therapy, CyberKnife Radiation Therapy, Naso-pharyngeal Radiation Therapy, Brachytherapy (internal seed implants))
|
-
0 (NaN%) experienced major perceived effectiveness
-
0 (NaN%) experienced moderate perceived effectiveness
-
0 (NaN%) experienced slight perceived effectiveness
-
0 (NaN%) experienced no perceived effectiveness
-
|
-
0 (NaN%) experienced severe side effects
-
0 (NaN%) experienced moderate side effects
-
0 (NaN%) experienced mild side effects
-
0 (NaN%) experienced no side effects
|
0 |
| <20 |
20s |
30s |
40s |
50s |
60s |
70+ |
| Current Age |
|
|
|
|
|
|
|
|
Distribution of females vs. males
| Gender |
| 9% |
Females |
| 91% |
Males |
Age at first symptom
| Age at first symptom |
# of patients |
Proportion |
|
0-19 years
|
1 |
|
|
20-29 years
|
4 |
|
|
30-39 years
|
4 |
|
|
40-49 years
|
2 |
|
|
50-59 years
|
0 |
|
|
60-69 years
|
0 |
|
|
70+ years
|
0 |
|
Diagnosis status
| Diagnosis status |
# of patients |
Proportion |
|
Diagnosed
|
16 |
|
Last updated: